| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |